Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2012:2012:928120.
doi: 10.5402/2012/928120. Epub 2012 Aug 9.

The opposing roles of cellular inhibitor of apoptosis proteins in cancer

Affiliations

The opposing roles of cellular inhibitor of apoptosis proteins in cancer

R Lau et al. ISRN Oncol. 2012.

Abstract

Cellular inhibitors of apoptosis proteins 1 and 2 (cIAP1/2) are members of the inhibitor of apoptosis protein (IAP) family that has been implicated in the pathology of human cancers due to their overexpression and function as blockers of cell death in various cancers. As a result, small molecule IAP antagonists have been developed and are currently under clinical evaluation for potential therapeutic use. In contrast, recent evidence has indicated a tumour-suppressing role for the cIAPs. Mutations in or loss of cIAPs have been identified as molecular lesions that contribute to constitutive activation of NF-κB in hematopoietic malignancies. These studies reveal a context-dependent role for the cIAPs wherein both their overexpression and loss may contribute to tumourigenesis.

PubMed Disclaimer

Figures

Figure 1
Figure 1
cIAP1/2 participates in positive and negative regulation of NF-κB. cIAP1/2 are recruited to an activated TNF receptor where they mediate K-63 polyubiquitination of RIP1. RIP1 subsequently activates the IKK complex, resulting in activation of canonical NF-κB complexes. In contrast, cIAP1/2 represses activation of canonical and noncanonical NF-κB signaling by ubiquitinating NIK, leading to its degradation. Mutation or loss of cIAP1/2 results in accumulation of NIK, resulting in activation of both canonical and noncanonical NF-κB. Activated NF-κB complexes promote the transcription of various growth and survival factors, such as IL6 (Interleukin 6) and BAFF (B-cell activating factor). cIAP, cellular inhibitor of apoptosis; IKK, IκB kinase; NIK, NF-κB inducing kinase; RIP, receptor interacting protein; TNF, tumour necrosis factor; TNFR, TNF receptor; TRAF, TNFR-associated factor; TRADD, TNFR-associated death domain.

Similar articles

Cited by

References

    1. Salvesen GS, Duckett CS. IAP proteins: blocking the road to death’s door. Nature Reviews Molecular Cell Biology. 2002;3(6):401–410. - PubMed
    1. Hinds MG, Norton RS, Vaux DL, Day CL. Solution structure of a baculoviral inhibitor of apoptosis (IAP) repeat. Nature Structural Biology. 1999;6(7):648–651. - PubMed
    1. Srinivasula SM, Ashwell JD. IAPs: what’s in a name? Molecular Cell. 2008;30(2):123–135. - PMC - PubMed
    1. Eckelman BP, Salvesen GS. The human anti-apoptotic proteins cIAP1 and cIAP2 bind but do not inhibit caspases. Journal of Biological Chemistry. 2006;281(6):3254–3260. - PubMed
    1. Hu S, Yang X. Cellular inhibitor of apoptosis 1 and 2 are ubiquitin ligases for the apoptosis inducer Smac/DIABLO. Journal of Biological Chemistry. 2003;278(12):10055–10060. - PubMed